← Back
$STOK All transactions

Stoke Therapeutics, Inc.

D

$ Value

$0

Shares

144,000

Price

$0

Filed

Sep 5

Insider

Name

Kaye Edward M. MD

Title

CIK

0001522780

Roles

Director

Transaction Details

Transaction Date

2025-09-04

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The reported transaction represents a disposition to the Issuer of equity securities that is exempt pursuant to Rule 16b-3(e) and 16b-6(d). The equity award was partially canceled for no consideration by mutual agreement of the reporting person and the Issuer. | The option began vesting on April 15, 2025. Pursuant to the terms of the initial grant, the original number of shares subject to the option vests in ratable increments monthly and the option shall be fully vested on December 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date. | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. | The reported transaction represents a disposition to the Issuer of equity securities that is exempt pursuant to Rule 16b-3(e) and 16b-6(d). The entire equity award was canceled for no consideration by mutual agreement of the reporting person and the Issuer. | Pursuant to the terms under which it was granted, the award was scheduled to vest as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date.

Filing Info

Accession No.

0001415889-25-023792

Form Type

4

Issuer CIK

0001623526

Kaye Edward M. MD's History

Date Ticker Type Value
2026-04-15 CYTK A $12K
2026-01-15 CYTK A $12K
2025-12-08 STOK $120K
2025-12-08 STOK $269K
2025-12-08 STOK $44K
2025-12-05 STOK $199K
2025-12-05 STOK $52K
2025-12-05 STOK $16K
2025-12-04 STOK $161K
2025-12-04 STOK $39K

Other Insiders at STOK (90d)

Insider Bought Sold Last
Ticho Barry
CHIEF MEDICAL OFFICER
$60K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$313K 2026-03-20